Effects of NMN! Potential to contribute to the health maintenance of pets

Mirai Lab Bioscience Corporation (Headquarters: Chuo-ku, Tokyo; CEO: Megumi Tanaka) will present the results obtained through collaborative research with Professor Toru Kimura from the Joint Faculty of Veterinary Medicine at the National University Corporation Yamaguchi University (Headquarters: Yamaguchi City, Yamaguchi Prefecture; President: Yukio Tanihara) at the 21st Asian Veterinary Association Congress. At this conference, we will report on the investigation of the effects of Nicotinamide Mononucleotide (NMN) administration on dogs and suggest findings that indicate the potential contribution of NMN administration to pet health maintenance.

For more information, please see the press release here.

Back to blog